Nomura Asset Management CO LTD Reata Pharmaceuticals Inc Transaction History

Nomura Asset Management CO LTD

13 transactions

Quarter	Operation	Price Per share	shares change
Q4 2021 Feb 01, 2022	SELL	$25.61 - $110.96 $0 - $0	0 Closed
Q3 2021 Jan 10, 2025	BUY	$100.0 - $143.02 $0 - $0	0 New
Q3 2021 Nov 12, 2021	BUY	$100.0 - $143.02 $0 - $0	0 New
Q2 2021 Jan 10, 2025	BUY	$78.27 - $151.29 $0 - $0	0 New
Q2 2021 Aug 06, 2021	BUY	$78.27 - $151.29 $0 - $0	0 New
Q1 2021 Jan 10, 2025	BUY	$94.25 - $132.81 $0 - $0	0 New
Q1 2021 May 14, 2021	BUY	$94.25 - $132.81 $0 - $0	0 New
Q4 2020 Jan 10, 2025	BUY	$102.03 - $184.62 $0 - $0	0 New
Q4 2020 Feb 12, 2021	BUY	$102.03 - $184.62 $0 - $0	0 New
Q3 2020 Nov 12, 2020	BUY	$93.53 - $163.34 $0 - $0	0 New
Q2 2020 Aug 13, 2020	BUY	$126.3 - $176.56 $0 - $0	0 New
Q1 2020 May 14, 2020	BUY	$124.16 - $247.74 $0 - $0	0 New
Q4 2019 Feb 13, 2020	BUY	$74.57 - $217.92 $0 - $0	0 New

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Nomura Asset Management CO LTD, based on Form 13F filings with the SEC.

Stay updated on Nomura Asset Management CO LTD with notifications on news.